Research any topic before you write.

Find related topics. | Discover entities. | See connections. | Build a topical map.

Tipranavir: Art & Overview

Tipranavir (TPV) is a nonpeptidic HIV-1 protease inhibitor manufactured by Boehringer Ingelheim under the trade name Aptivus. It is used as part of combination antiretroviral therapy for treatment-experienced patients with HIV-1 infection whose virus is resistant to more than one protease inhibitor. It is not approved for treatment-naïve patients.

Language: English [EN]
Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.
100%
More settings
100% 100% 100% 100% 100%

Tipranavir topic overview

The analysis highlights Art and Overview as prominent areas in the source structure around Tipranavir.

Related topics
15
Source areas
1
Connected nodes
16
Extracted relationships
35
Concept neighborhoods
14
Bridge connections
16

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

Overview · 15 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

3D model (JSmol)
Interactive image
AHFS/Drugs.com
Monograph
ATC code
J05AE09 (WHO)
CAS Number
174484-41-4 Y
ChEMBL
ChEMBL183041 N
ChemSpider
10482313 Y

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Overview

Advanced semantic analysis

Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.

How Tipranavir connects Entity context

The extracted context around Tipranavir shows recurring relationship patterns in the source. For example, Tipranavir → Archived, August, Drug Information Portal, Medicine, National Library Another extracted example is Tipranavir → EU: Rx-only, UK: POM (Prescription only), US: ℞-only. Use these groups to spot repeated connection types before inspecting the individual relationships.

Tipranavir

Top relations

related to External links · 5
Tipranavir → Archived, August, Drug Information Portal, Medicine, National Library
Legal status · 3
Tipranavir → EU: Rx-only, UK: POM (Prescription only), US: ℞-only
License data · 3
Tipranavir → EU EMA: by INN, US DailyMed: Tipranavir, US FDA: Tipranavir
3D model (JSmol) · 1
Tipranavir → Interactive image
AHFS/Drugs.com · 1
Tipranavir → Monograph
ATC code · 1
Tipranavir → J05AE09 (WHO)
CAS Number · 1
Tipranavir → 174484-41-4 Y
ChEMBL · 1
Tipranavir → ChEMBL183041 N
ChemSpider · 1
Tipranavir → 10482313 Y
CompTox Dashboard (EPA) · 1
Tipranavir → DTXSID6048622

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

patients protease drug hiv-1 aptivus inhibitor ritonavir hepatotoxicity used combination antiretroviral therapy treatment-experienced resistant approved resistance june salvage current side

Tipranavir relationships Subject–Predicate–Object triples

TTTA extracted 35 structured relationships around Tipranavir. Examples in this analysis include Tipranavir → 3D model (JSmol) → Interactive image and Tipranavir → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.

SubjectPredicateObjectConfidenceSrc
Tipranavir3D model (JSmol)Interactive image1.00infobox
TipranavirAHFS/Drugs.comMonograph1.00infobox
TipranavirATC codeJ05AE09 (WHO)1.00infobox
TipranavirCAS Number174484-41-4 Y1.00infobox
TipranavirChEMBLChEMBL183041 N1.00infobox
TipranavirChemSpider10482313 Y1.00infobox
TipranavirCompTox Dashboard (EPA)DTXSID60486221.00infobox
TipranavirDrugBankDB00932 Y1.00infobox
TipranavirECHA InfoCard100.158.0661.00infobox
TipranavirElimination half-life4.8–6 hours1.00infobox
TipranavirExcretionFeces (82.3%), urine (4.4%)1.00infobox
TipranavirFormulaC31H33F3N2O5S1.00infobox
TipranavirLegal statusUK: POM (Prescription only)1.00infobox
TipranavirLegal statusUS: ℞-only1.00infobox
TipranavirLegal statusEU: Rx-only1.00infobox
TipranavirLicense dataEU EMA: by INN1.00infobox
TipranavirLicense dataUS DailyMed: Tipranavir1.00infobox
TipranavirLicense dataUS FDA: Tipranavir1.00infobox
TipranavirMedlinePlusa6060091.00infobox
TipranavirMetabolismLiver1.00infobox
TipranavirMolar mass602.67 g·mol−11.00infobox
TipranavirNIAID ChemDB0329411.00infobox
TipranavirPDB ligandTPV (PDBe, RCSB PDB)1.00infobox
TipranavirPregnancy categoryAU: B31.00infobox
TipranavirPronunciation/tɪpˈrænəvɪər/ tip-RAN-ə-veer1.00infobox
TipranavirProtein binding99.9%1.00infobox
TipranavirPubChem CID546824611.00infobox
TipranavirRoutes of administrationBy mouth (soft capsules)1.00infobox
TipranavirTrade namesAptivus (AP-tiv-əs)1.00infobox
TipranavirUNIIZZT404XD091.00infobox

Related concept clusters Concept neighborhoods

The concept neighborhoods around Tipranavir bring nearby vocabulary together. In this analysis, examples include Protease, Administration and Capsules. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

  • Tipranavir
    • Protease
    • Administration
    • Capsules
    • Drugs
    • Fda
    • Name
    • Ritonavir
    • Tpv
    • Trade
    • Aptivus
    • Hiv-1
    • Boehringer
  • tipranavir
    • Protease
    • Administration
    • Capsules
    • Drugs
    • Fda
    • Name
    • Ritonavir
    • Tpv
    • Trade
    • Aptivus
    • Hiv-1
    • Boehringer
  • hiv-1
    • Protease
    • Inhibitor
    • Resistant
    • Boehringer
    • Ingelheim
    • Manufactured
    • Nonpeptidic
    • Part
    • Patients
    • Antiretroviral
    • Combination
    • Name
  • protease
    • Inhibitor
    • Resistant
    • Tipranavir
    • Patients
    • Boehringer
    • Ingelheim
    • Manufactured
    • Part
    • Antiretroviral
    • Combination
    • Name
    • Resistance
  • inhibitor
    • Boehringer
    • Ingelheim
    • Manufactured
    • Nonpeptidic
    • Part
    • Protease
    • Antiretroviral
    • Combination
    • Name
    • Resistant
    • Therapy
    • Tpv
  • food and drug administration
    • Capsules
    • Fda
    • Drugs
    • June
    • Name
    • Tpv
    • Trade
    • Aptivus
    • Cholesterol
    • Tipranavir
    • Triglycerides
    • Current
  • boehringer ingelheim
    • Ingelheim
    • Manufactured
    • Nonpeptidic
    • Inhibitor
    • Name
    • Tpv
    • Trade
    • Aptivus
    • Hiv-1
    • Protease
    • Tipranavir
  • intracranial hemorrhage
    • Hemorrhage
    • Intracranial
    • Hepatitis
    • Hyperglycemia
    • Hepatotoxicity
    • Side

Connections between topic areas Semantic bridges

Bridges highlight paths between different parts of the Tipranavir map and can reveal research angles that are easy to miss in a flat list.

Min side: 3

Map overview Semantic statistics

Tipranavir

Nodes17
Edges16
Triples35
Avg. degree1.88
Density0.117647
Components1

Source & methodology

TTTA analyzes the structure around Tipranavir to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Art & Overview, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — Tipranavir · EN edition · Analysis: TopicsToTalkAbout

For writers, content strategists, SEOs, marketers and creators — from quick topic research to advanced semantic analysis.